Results 191 to 200 of about 477,848 (284)

Recrudescence of tuberculosis in the state of São Paulo post-COVID-19: trends and clusters. [PDF]

Rev Saude Publica
Tavares RBV, Zini N, Alves YM, Vinci ALT, Ribeiro NM, Tártaro AF, Caripa VCA, Pelodan MEP, Souza CF, Monroe AA, Ballestero JGA, Pinto IC, Palha PF, Arcêncio RA.   +13 more
europepmc   +1 more source

Participation for mental health service development in China: Conditions, challenges, facilitators, and outcomes

American Journal of Community Psychology, EarlyView.
Abstract This study analyzes a participatory project to develop peer support services for people with serious mental illnesses (SMIs) in China. Drawing on interviews with psychiatrists, social workers, service users, and a family caregiver, it examines the conditions, challenges, facilitators, and outcomes of participation in a paternalistic context ...
Zhiying Ma, Yu Fan, Xiyuan Chen, Lindsay Sheehan, Sang Qin, Aoxuan Cao, Liang Zhou   +6 more
wiley   +1 more source

Epidemiological and immunological insights into respiratory infections in post-COVID-19. [PDF]

Front Cell Infect Microbiol
Wang Z, Li Y, Cai J, Sun Y, Maimaiti M, Liu Y, Yang C, Liu W, Li S, Ren Y, Chen Y, Yang Q, Xu Y, Yi J.   +13 more
europepmc   +1 more source

COVID-19 impact on higher education providers : funding, regulation and reporting implications. 04 May 2020 [PDF]

, 2020

core  

Giving and receiving help in three contexts as predictors of alcohol outcomes in a longitudinal study of sober living house residents

American Journal of Community Psychology, EarlyView.
Abstract Although peer support is central to the social model approach emphasized in sober living houses (SLHs), no longitudinal studies have examined helping among SLH residents. This longitudinal study examined benefits of helping in three contexts among SLH residents. Data were from 205 participants entering 28 SLHs across 2021–2023. Interviews were
Sarah E. Zemore, Elizabeth Mahoney, Meenakshi S. Subbaraman, Amy A. Mericle, Douglas L. Polcin   +4 more
wiley   +1 more source

Fixed‐Duration Subcutaneous Mosunetuzumab in Relapsed/Refractory Follicular Lymphoma: Pivotal Phase 2 Primary Analysis

American Journal of Hematology, EarlyView.
ABSTRACT Mosunetuzumab is approved as an intravenous (IV) formulation for relapsed/refractory (R/R) follicular lymphoma (FL) after ≥ 2 prior therapies. A subcutaneous (SC) formulation, aiming to improve patient safety and convenience, has been developed.
Nancy L. Bartlett, Laurie H. Sehn, Sarit Assouline, Pratyush Giri, John Kuruvilla, Stephen J. Schuster, Sung‐Soo Yoon, Keith Fay, Georg Hess, Martin Dreyling, Norma C. Gutierrez, Eva Cybulski, Fidelis Sabalvaro, Elicia Penuel, Vanda Teodoro, Samuel Tracy, Denison Kuruvilla, Joseph Chen, Volker Wiebking, Michael C. Wei, L. Elizabeth Budde   +20 more
wiley   +1 more source

Association Between Obesity and Post-COVID-19 Condition in Military Conscripts. [PDF]

J Clin Med
Domanyi R, Maitz E, Andrianakis A.
europepmc   +1 more source

Real‐World Effectiveness and Safety of Ravulizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria: Evidence From the International PNH Registry

American Journal of Hematology, EarlyView.
ABSTRACT Ravulizumab, a second‐generation complement component 5 inhibitor (C5i) derived from eculizumab, with improved pharmacokinetics, is the current standard‐of‐care treatment for patients with paroxysmal nocturnal hemoglobinuria (PNH), where available.
Alexander Röth, Christopher J. Patriquin, Jeff Szer, Louis Terriou, Ami S. Patel, Jesse Metzger, Philippe Gustovic, Jun‐ichi Nishimura, Robert A. Brodsky   +8 more
wiley   +1 more source

A short version of the post-COVID-19 condition stigma questionnaire. [PDF]

Public Health Pract (Oxf)
Rourke L, Damant R.
europepmc   +1 more source

Coronavirus (COVID-19): supporting pupils, parents and teachers: learning during term 4 [PDF]

, 2020

core